Tuesday, October 29, 2019
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (CSE: $AUSA.C) (OTC: $EPAZ) (OTCQB: $SING) (CSE: $CRFT.C) (TSX: $FAF.TO)
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (CSE: $AUSA.C) (OTC: $EPAZ) (OTCQB: $SING) (CSE: $CRFT.C) (TSX: $FAF.TO)
Delta, Kelowna, BC –October 29, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/10291AUSA-EPAZ-SING-CRFT-FAF.asp
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts
In today’s podcast we look at a few early announcements.
But first, Hempcorp recently secured a 10,000 acre site set to become the world's largest hemp plantation. This comes following the legalisation of hemp cultivation within the state of Uttarakhand, India.
The company will be managing operations in Uttarakhand and has plans for a variety-based product chain from hemp. The product chain will vary from health foods, cosmetics, textiles, FMCGs, pharmaceuticals, cannabis-infused ayurvedic medicines, eco-friendly construction materials, bioplastics, biofuel and more. Hemp-based paper, plastics and fuel will foster a more sustainable future.
The company has been engaging with government officials and liaisons regarding regulatory compliance. A recent industry development was made by the government in licensing cannabis cultivation, processing and refinement for the production of ayurvedic medicines containing CBD and THC content.
The company has made the recent decision to proactively participate in the formation of a cannabis society for the decriminalisation, legalisation and advocacy of cannabis in India. Further, is in partnership discussions with technologists regarding bleeding edge technologies in cannabinoid extraction.
Hempcorp expects the market to grow at an exponential rate over the next 3 years into a multi-billion-dollar industry and is seeing a growing interest in foreign investment into India's cannabis space. Given these factors, the company is also focusing on the creation of an Indian hemp market.
Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) announced the formation of Cocoon Technology LLC, a cloud-based, self-service fulfillment platform and wholly-owned subsidiary of AUSA. Designed to enhance the consumer experience and reduce labor costs, Cocoon delivers operational efficiency to dispensaries while improving order fulfillment, cash management, bankcard acceptance, data analytics, customer loyalty, marketing, privacy, and compliance. Cocoon's Platform-as-a-Service model delivers contracted recurring revenue, one-time revenue, exclusive multi-year agreements, enhanced product offerings and an extensive runway of future innovations.
With the launch of CocoonPod®, Cocoon unites state-of-the-art self-service kiosks with mobile applications, platform agnostic integrations into leading enterprise resource planning (ERP)/business management systems, and payment providers. CocoonPod® features consumer-facing kiosks as stand-alone units or multi-unit pods as the core consumer point-of-interaction (POI), coupled with a consumer mobile application and tablet for employee assisted self-service transactions, providing a full omni-commerce solution for brick-and-mortar locations.
"The benefits of deploying self-service technology have been demonstrated across all brick-and-mortar retail sectors in the United States and AUSA's management experience and leadership in self-service technology positions AUSA for immediate success across North America," states Michael Carlotti, Chief Financial Officer of AUSA. "The estimated market opportunity for kiosk sales to dispensaries in the United States over the next five years is 50,000 units with a recurring revenue model based on a percentage of sales initiated within CocoonPod®. Cocoon has met with leading Multi-State Operators (MSO) and focus groups with conservative assumptions suggesting 60-80% of returning customers will choose to initiate their purchase through a self-service POI."
CocoonPod® functionality delivers reduced transaction times, privacy, coin-less cash recycling, payment gateway, ATM processing, ID validation, QR codes, consumer loyalty, charitable donations, and numerous marketing opportunities through a dynamic user interface. By integrating Coil®, a loyalty and data application built by AUSA's wholly-owned subsidiary Rthm Technologies ("Rthm"), CocoonPod® also offers fully integrated loyalty functionality for consumers, now branded as CocoonRewards®.
"Since being acquired by AUSA the Rthm team has created the industry's most powerful data-driven mobile loyalty application which will integrate directly within the CocoonPod® platform providing operators and consumers a user experience and point-of-purchase options never before available," states Alex Mosa, President of Rthm. "We are excited to release this impactful product into the U.S. market."
CocoonPod® self-service kiosks and integrated form factors were developed in partnership with Passport Technology Inc. ("Passport"), the International award-winning technology provider to brick-and-mortar casinos and hospitality. With over a decade of experience developing robust, intuitive, aesthetically pleasing self-service kiosk technology, payment applications, loyalty rewards, compliance programs, and opt-out optionality to highly regulated and high traffic industries, Passport's reputation of developing and supporting these technologies is unparalleled.
"As the industry continues to expand, retailers seek opportunities to streamline operations and enhance consumer experiences. CocoonPod® is the future for highly regulated brick-and-mortar environments where privacy, Know Your Customer (KYC), Anti-Money Laundering (AML), and social responsibility are critical," states Kurt Sullivan, President of Passport. "Our partnership with Cocoon will immediately address known pain points while introducing new functionality for all stakeholders within the dispensary and retail eco-system."
Epazz, Inc. (OTC: EPAZ), a leading provider of drone technology, blockchain mobile apps and cloud-based business software solutions, has announced that its holdings ZenaPay, Inc. has signed five beta customer agreements in order to commercialize its drone smart farming solution. The ZenaPay team in August 2019 beta tested its drone mapping and plant tracking solutions in Ireland on two farms. The beta test was a success, signing up additional beta customers. The company has been updating the software and developing its own drone technology based on the feedback from the Ireland trip.
Epazz, Inc., which formed Farm Drone, Inc. earlier this year, will license exclusively its drone technology to ZenaPay, Inc. The drone will be called ZenaDrone 1000. It will be the first generation drone we develop for the Agriculture industry. ZenaDrone 1000 will be a workhorse for farms, which will have multiple functions and features to scan fields and remove the male hemp plant in order to double female hemp production. The feedback we received from our trip to Ireland has provided us an opportunity to extend our technology to include tracking livestock and testing soil samples.
Epazz will be maintaining its twitter page with updates about the drone development and the company on a daily basis. You can visit our twitter page at https://www.twitter.com/epazz
Dr. Shaun Passley, CEO of Epazz & ZenaPay, said, “We believe that Artificial Intelligence (“AI”) and our facial recognition technology are the next technologies to positively impact agriculture production. Our agreements with 5 beta customers will demonstrate the benefits of the ZenaPay Drone Farm Software; and the efficiency gained from tracking plant growth from seed to harvest.”
SinglePoint, Inc. (OTCQB: SING) has launched into the smokable hemp market. Their newly released brand 1606 Original Hemp is gaining traction after much attention at the 2019 National Association of Convenience Stores launch. The company received orders on site at the show and gathered over 100 interested clients that collectively own over 15,000 locations. SinglePoint expects to make its first large sale in the near future and has shipped orders to a collective 250 locations.
Pure American Hemp cigarettes are nicotine and tobacco free. Some research suggests that smoking hemp cigarettes could be a potential tool to replace tobacco and nicotine addictions. According to a Brightfield Group survey of more than 5,000 CBD users in the U.S.:
● 24% have used it to help quit smoking.
● Quitters are often replacing cigarettes
with either smokable hemp or vaping.
with either smokable hemp or vaping.
● 41% of quitters have entirely replaced
tobacco with hemp CBD.
tobacco with hemp CBD.
Google trends reveals over the last year that hemp was researched more often than tobacco and nicotine.
The Alternative Market has continued to grow by 35%, from 2019 to 2018 while cigarettes stayed steady at 3.1%. With the addition of hemp cigarettes and the recent vape scare, many assume the alternative market will continue growing as people look for a “healthier for you” alternative to cigarettes.
Fire & Flower Holdings Corp. (TSX: FAF) and its wholly-owned subsidiary HifyreTM Inc., announced the successful launch of the Spark PerksTM cannabis members program across the Fire & Flower retail network.
Members of the Spark Perks program receive exclusive benefits including: Fastlane checkout, special deals, member-only events and exclusive content. Spark Perks is free to join and no cannabis purchase is required to join the program.
Since the program's official launch on September 19, 2019, Spark Perks has grown to more than 38,000 members. Of those members, 33% have conducted a second transaction since the creation of the member profile. Initial results indicate that on average, Spark Perks members spend 43% more than non-members, per transaction, in the Fire & Flower retail network.
"Since the launch of the Spark Perks program, Fire & Flower has seen an increase in customer engagement and basket size of members across our retail network," shared Trevor Fencott, Chief Executive Officer of Fire & Flower. "The launch of the Spark Perks member program demonstrates Fire & Flower's continued commitment to be a leading data-driven, 'retail 2.0' company."
"Hifyre has been developing Spark Perks for more than six months and we are delighted to see positive initial results in the member program," shared Matthew Hollingshead, President of Hifyre. "Hifyre continues to be at the forefront of digital cannabis retail. We focus on developing secure, data driven retail tools that connect customers with the brands and products they love."
Pasha Brands Ltd. (CSE: CRFT) (OTC: CRFTF) commented on the legal retail market in Canada and what separates them from the competition.
Between 2014 and 2018 global sales of legal cannabis more than tripled from $3.4 billion to $10.9 billion, according to the State of the Legal Cannabis Markets report from Arcview Market Research. BDS Analytics calls for a near-quadrupling from 2018 levels to $40.6 billion by 2024 at an annual growth rate of 21.9%. This has led many people to wonder, why the recent market downturn in the cannabis sector?
"Legal cannabis, particularly in Canada, has been struggling under the weight of burdensome regulations, poor supply-chain management, and quality issues," said Jamie Shaw, Chief Communications and Culture Officer for Pasha. "Coupled with that, companies in the sector were slow to deliver the results expected and were generally seen as overvalued. Share prices were determined at a time when there were relatively few licences that seemed to have a stranglehold on the regulated marketplace."
While these challenges are most pronounced in today's market, for Pasha it has been an affirmation of its business plan. "We never bought into the big-box mentality that's causing many of these problems," Shaw said. "Pasha has focused on small batch, craft producers, and has been meeting its goals at a quick pace, with the first micro-cultivation harvest expected in December."
Pasha has been on-boarding brands and people that made legalization possible, including Baked Edibles, Earth Dragon Organics, and Beard Brothers Collective, and has acquired a Health Canada licensed facility on Vancouver Island. Pasha expects to be the first licensed, nation-wide, all-craft company to be operational by end of Q4 2019/early Q1 2020.
Of the first 5 micro-licences issued by Health Canada, Pasha has signed supply agreements with all of them. Pasha also has signed supply agreements with 60 more applicants currently in the CTLS queue with Health Canada, and another 40 navigating the licensing process with Pasha subsidiary, BC Craft Supply Co. Ltd. With 100 micro-cultivators each permitted to produce up to 500kg per year, Pasha could have the ability to bring up to 50,000kg per year of high-quality craft cannabis to Canadian consumers.
"The legal market has yet to see products with the same care and attention to detail that went into the highest quality, illicit products," said Patrick Brauckmann, Executive Chair of Pasha Brands. "Pasha is committed to bringing products to the marketplace that put the consumer first."
Partnered with powerful distributors like Great North and developing innovative industry solutions like Craft Labs, Pasha looks to disrupt how people think of legal cannabis.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure : (OTCQB: SING) is a paid annual news and social media company on Investorideas.com More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
SinglePoint Inc. (OTCQB: $SING): #Hemp Cigarettes - What You Need to Know About One of the Fastest Growing Segments of Hemp; @_Singlepoint_
SinglePoint Inc. (OTCQB: $SING): #Hemp Cigarettes - What You Need to Know About One of the Fastest Growing Segments of Hemp; @_Singlepoint_
PHOENIX - October 29, 2019 (Investorideas.com Newswire) SinglePoint, Inc. (OTCQB:SING) has launched into the smokable hemp market. Newly released brand 1606 Original Hemp is gaining traction after much attention at the 2019 National Association of Convenience Stores launch. The company received orders on site at the show and gathered over 100 interested clients that collectively own over 15,000 locations. SinglePoint expects to make its first large sale in the near future and has shipped orders to a collective 250 locations.
Hemp has been globally cultivated for thousands of years, but what is hemp and what makes the plant so special? Hemp is a strain that comes from the Cannabis Sativa plant species, it is an agricultural crop grown for seed and fiber. "Some of the earliest known uses of hemp began in China about 10,000 BCE, where it was used for making clothing, rope, and paper."
In today's world, hemp is becoming very popular. The use of hemp has evolved into diverse products such as lotions, oils, food, beverages, and cigarettes. Smokable hemp is a developing trend, but is it a good way to consume the cannabinoid? Here's what you need to know:
Hemp vs. Marijuana
Hemp and marijuana are both part of the cannabis family. However, hemp will not get you high unlike marijuana, which is known for its psychoactive effects. Marijuana has high levels of THC, containing anywhere from 5%-35% whereas hemp has less than 0.3% THC. Hemp contains high cannabidiol (CBD) content which is not psychoactive. Smoking hemp is a positive alternative to marijuana, "You get the same taste, the same psychological feeling of smoking a joint, but without the high."
Replacing Tobacco
Pure American Hemp cigarettes (link) are nicotine and tobacco free. Some research suggests that smoking hemp cigarettes could be a potential tool to replace tobacco and nicotine addictions. According to a Brightfield Group survey of more than 5,000 CBD users in the U.S.:
· 24% have used it to help quit smoking.
· Quitters are often replacing cigarettes
· with either smokable hemp or vaping.
· 41% of quitters have entirely replaced
· tobacco with hemp CBD.
Google trends reveals over the last year that hemp was researched more often than tobacco and nicotine.
Initial Research
Initial research has shown CBDs ability to reduce cigarette consumption. Researchers at University College London conducted a study of 24 smokers. Each were given an inhaler with CBD or placebo. For one week they were to use the inhaler when they had the urge to smoke. Those with placebo had no difference in cigarettes smoked, those with the CBD inhaler significantly reduced the number of cigarettes smoked by 40%.
The Alternative Market
The Alternative Market has continued to grow drastically, 35%, from 2019 to 2018 while cigarettes stayed steady at 3.1%. With the addition of hemp cigarettes and the recent vape scare, many assume the alternative market will continue growing as people look for a "healthier for you" alternative to cigarettes.
The Future
BDS Analytics and Arcview Market Research projects that the collective market for CBD sales in the U.S. will surpass $20 billion by 2024 while New York-based investment bank Cowen & Co, estimates that the market could pull in $15 billion by 2025. The smokable hemp market currently represents approximately 2% of the overall CBD market, but with a 250% growth from 2017 to 2018, Brightfield Group, a Chicago-based cannabis market research firm, identifies dried and smokable hemp flowers as one of the fastest-growing segments of the CBD market.
About SinglePoint, Inc.
SinglePoint, Inc (SING) is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The company portfolio includes mobile payments, ancillary cannabis services and blockchain solutions. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base. Through SingleSeed, the company is providing products and services to the cannabis industry.
Connect on social media at:
Forward-Looking Statements
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.
Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.
Corporate Communication
SinglePoint Inc.
855-711-2009
investors@SinglePoint.com
SinglePoint.com
855-711-2009
investors@SinglePoint.com
SinglePoint.com
More info on SING at Investorideas.com Visit: https://www.investorideas.com/CO/SING/
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. For Disclosure purposes SinglePoint Inc (OTCQB: SING) is a paid annual news and social media company on Investorideas.com. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp and https://www.investorideas.com/About/News/Clientspecifics.asp . Learn more about our prices for publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories
Hot #Cannabis #Stocks - It’s Always Sunny in #Israel; (CSE: $IPOT) (TSXV: $KHRN.V) (TSX: $AVCN.TO) (TSXV: $PCLO.V)
Hot #Cannabis #Stocks - It’s Always Sunny in #Israel; (CSE: $IPOT) (TSXV: $KHRN.V) (TSX: $AVCN.TO) (TSXV: $PCLO.V)
Snapshot Looking at Cannabis Global Expansion from Israel to the EU
Point Roberts WA, Delta, BC – October 29, 2019 - Investorideas.com, a leading investor news resource covering cannabis and hemp stocks releases a sector snapshot reporting on the continued international expansion of the cannabis industry and how it’s leading to a global cannabis infrastructure.
Read this in full at https://www.investorideas.com/news/2019/cannabis/10291Israel.asp
A recent article reporting on the growth of the global cannabis industry notes, “Fully 185 countries are signatories to the United Nations’ Single Convention on Narcotic Drugs of 1961, which prohibits cannabis as a drug that can be abused and cause ill effects, without bringing a substantial therapeutic advantage. Each signatory’s laws must reflect the Convention; that is the case for the US’ Controlled Substances Act of 1971. Countries that have legalized cannabis are flouting the convention, and some, such as Canada, admit that openly.”
“Thanks to changing public perceptions, moves such as Canada’s, ongoing research on health benefits and risks, and the urging of the World Health Organization—in 2019 it came out in favor of less restrictive control of cannabis and of removing prohibitions for pure CBD and CBD preparations containing no more than .2% THC—the United Nations has said it will revisit cannabis under the Single Convention. It should be noted, however, that amending the convention is difficult with so many members involved.”
“Medical use of cannabis is and will be accepted around the world a lot more quickly than recreational use,” says Mario Torres of Brazeau Seller Law (Ottawa, Ontario, Canada). “People are not enthused about prohibiting medical care. They don’t want to disallow access to the only thing that may stop epileptic seizures in children or is part of a patient’s treatment plan.” Medical use is becoming more acceptable even in very conservative countries like South Korea and Thailand, which have legalized cannabis for medical purposes.
Recent news headlines look to Israel saying,” Israel is at the forefront of cannabis tech. The country, which produces more pharmaceutical cannabis than just about anywhere else, is poised to become a leading exporter.”
Recently listed on the CSE, Isracann Biosciences Inc. (CSE: IPOT) is an Israeli-based cannabis company focused on becoming a premier cannabis producer offering low-cost production targeting undersupplied, major European marketplaces. The Company (formerly Atlas Blockchain Group Inc.), recently provided an operative overview and update regarding facility development activities in Israel.
Concurrent to and as part of the Company’s recent listing on the Canadian Securities Exchange it had satisfied the escrow release conditions for the net proceeds of its highly successful CAD$10.1 million financing efforts which bolstered an already healthy cash position.
This positions the company to immediately accelerate its planned Phase One Facility Design and Construction Services Program which consists of finalization of greenhouse facility design for cannabis cultivation and production in accordance with an existing technical specifications strategy; to rapidly advance greenhouse and related facility construction per the design; ensure adequate controls are in place against any diversion, theft and loss of cannabis products per regulatory standards; and ensure compliance with other protective security, health, and safety requirements in accordance with Israeli regulations.
To date, Isracann has entered into agreements for the development of medical cannabis cultivation projects with regional stakeholders holding preliminary breeding and cultivation licenses issued by the Israeli Ministry of Health. The regional stakeholder is required to renew these licenses each year and further bears the cost of electricity, property and related land taxes and are bound to working with Isracann to obtain the required licenses and to participate in the construction of the greenhouses.
Isracann ‘s CEO, Darryl Jones notes, “We are very pleased to have achieved our very important initial milestone targets with the CSE listing of our ticker symbol “IPOT” and to confirm our accelerated investment plans in Israel are fully underway. We have lined up several key organizations and personnel and look forward to announcing a number of these key commercial agreements in the days and weeks ahead. We thank all our supporters for their belief in us, and in our belief that the Israeli agricultural sector will provide a huge leading role in positioning the Isracann brand as market leaders in the massive and underserved European cannabis marketplace.”
In related news, the Company welcomes the recent appointment of Irit Arbel, Ph.D. to its Board of Directors. Dr. Arbel brings significant senior multidisciplinary biopharma and governance experience to Isracann’s board. She serves as CEO, Co-Founder and Director of Neurocords Ltd., a company focused on developing new treatments for peripheral and spinal cord regeneration, and previously served as Director and President of Brainstorm Cell Therapeutics, and as Executive Vice President of Research and Development at Savicell Diagnostic, a biotechnology company. Dr. Arbel previously served as Chairperson of Real Aesthetics, a company specializing in cellulite ultrasound treatment, and BRH Medical, a developer of medical devices for wound healing. She was also Director of M&A at RFB Investment House, a private investment firm focusing on early-stage technology-related companies. Previously, Dr. Arbel was President and Chief Executive Officer of Pluristem Life Systems, a biotechnology company, and prior to that as Israeli Sales Manager of Merck, Sharp & Dohme, a pharmaceutical company. Dr. Arbel earned her Ph.D. in 1997 in Neurobiology, after performing research in the area of MS. Dr. Arbel also holds a Chemical Engineering degree from the Technion, Israel’s Institute of Technology.
Avicanna Inc.(TSX: AVCN) (OTCQX: AVCNF), a biopharmaceutical company focused on the development, manufacturing and commercialization of cannabinoid-based products, recently announced that Santa Marta Golden Hemp S.A.S., its majority owned subsidiary, has completed commercial exports of its Aureus™ brand of CBD-based products to South Africa and the United Kingdom.
The Aureus brand of products include an organic and sustainable line of plant-derived active pharmaceutical ingredients ("APIs") and bulk CBD formulations developed by Avicanna in collaboration with SMGH and Sativa Nativa S.A.S. ("Sativa Nativa"), which is also a majority owned subsidiary of Avicanna. These initial sales included the export of CBD isolate and 4% bulk formulation for CBD oil sublingual sprays. Each of the above exports has been completed in accordance with all applicable laws in the Jurisdictions.
Aras Azadian, Avicanna's Chief Executive Officer, stated "We are excited to bring the Aureus brand of cannabinoid APIs to our international customers. We believe these initial sales further validate the brand's opportunities in these two countries, as well as the potential for us to actively market our APIs across the globe to manufacturers of CBD products. We believe the Aureus brand of API products will become a leader in organic and sustainable cannabinoid raw materials and the gold standard with respect to global quality controls, which we believe are necessary for the evolution of a worldwide cannabinoid industry.”
Avicanna is also looking into the Latin American market having announced the retail launch of its Pura Earth™ derma-cosmetics line of CBD products, which are now available at approximately 59 high-end retail locations throughout Colombia, including Blind Prestige beauty shops and Cromantic professional beauty markets.
Khiron Life Sciences Corp. (TSXV: KHRN) (OTC: KHRNF), a vertically integrated cannabis leader with core operations in Latin America, recently announced their entrance into the EU market having completed the EU cosmetic regulatory process for seven Kuida products, and received a "no objection" letter from TSXV with respect to distribution of these products in the UK.
Tejinder Virk, President, Khiron Europe, commented, "The fulfillment of EU cosmetic regulatory requirements allows the Company to bring our proven product line into the sophisticated and growing European skincare market, where we expect to rapidly build and grow Kuida's market share. We will initially focus on import and marketing in UK, with our first sales expected in Q1 2020, before expanding to Spain, Germany and the broader European market, subject to the specific requirements of individual member states and TSXV approval."
Kuida®, the first consumer brand of Khiron's wellness business unit, brings the benefits of cannabidiol (CBD) to a comprehensive portfolio of skin and body care products for women. Kuida was launched in Colombia in October 2018 through retail, wholesale and online channels and is now available nationwide and through e-commerce channels. As the Company expands Kuida® distribution in Europe, the brand will be a featured exhibitor at Cosmoprof Worldwide Bologna 2020, which attracted over 265,000 visitors in 2019 and is the largest such event to learn more about market leading products and to place orders.
The company also participated in the Open Parliament held by Senate of Mexico on the theme of "Towards Cannabis Regulation," which took place through August 2019 and September 2019. As a Latin American cannabis leader with a strong presence in Mexico, Khiron joined both open forum sessions and a committee of experts to engage in dialogue and provide input on the building blocks of the country's new regulatory framework.
PharmaCielo Ltd. (TSXV:PCLO) (OTC: PHCEF), whose anticipated acquisition of Australian Securities Exchange ("ASX") listed Creso Pharma will establish a global medicinal cannabis company positioned to rapidly develop new markets and grow sales in the expanded footprint served by the combined company, recently announced key developments in respect of its acquisition originally announced on June 6, 2019. Creso Pharma has informed the Company that it has received approval from the Supreme Court of Western Australia to convene meetings of its shareholders and listed option holders, and if thought fit, to approve the Schemes of Arrangement whereby PharmaCielo would acquire all of the issued and outstanding shares and listed options of Creso Pharma. The Meetings will be held on November 11, 2019, beginning at 10:00AM (Perth time).
The Board of Directors of Creso Pharma continue to unanimously recommend that Creso Pharma Shareholders and the Creso Pharma Optionholders vote in favour of the proposed Schemes of Arrangement, in the absence of a superior proposal for Creso Pharma.
David Attard, CEO of PharmaCielo commented, "PharmaCielo's acquisition of Creso Pharma, creates a combined company that has operational excellence across the value chain. The quality and scale of PharmaCielo's cultivation and extraction compliments Creso Pharma's product development and extensive developed global sales channels. With the Creso Pharma acquisition and our recently announced agreement to export CBD into the United States , 2020 is going to be an exciting year for PharmaCielo shareholders."
PharmaCielo expects that the combined company will be well-positioned to drive significant value for both existing PharmaCielo and Creso Pharma shareholders.
PharmaCielo has received conditional approval from the TSX Venture Exchange for the issuance of common shares of PharmaCielo to Creso Pharma Shareholders and Creso Pharma Optionholders in order to effect the Schemes of Arrangement. The effective date of the Schemes of Arrangement is expected to be November 13, 2019; and the closing date of the acquisition is expected to be November 22, 2019.
With the growing international acceptance of the cannabis industry, companies with strongly established infrastructure in key global trade areas will become more of an essential asset as the industry moves further towards global standards and sales.
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining, the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
Disclosure: this news article featuring CSE: IPOT is a paid for news release on Investorideas.com – third party (two thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories
Subscribe to:
Posts (Atom)